Anuh Pharma Limited (BOM:506260)
76.07
-1.47 (-1.90%)
At close: Mar 4, 2026
Anuh Pharma Market Cap
Anuh Pharma has a market cap or net worth of 7.62 billion as of March 5, 2026. Its market cap has decreased by -15.01% in one year.
Market Cap
7.62B
Enterprise Value
7.50B
Revenue
7.68B
Ranking
n/a
PE Ratio
18.22
Stock Price
76.07
Market Cap Chart
Since January 2, 2008, Anuh Pharma's market cap has increased from 219.45M to 7.62B, an increase of 3,374.21%. That is a compound annual growth rate of 21.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 7.62B | -5.48% |
| Dec 31, 2025 | 8.07B | -28.75% |
| Dec 31, 2024 | 11.32B | 54.09% |
| Dec 29, 2023 | 7.35B | 64.17% |
| Dec 30, 2022 | 4.48B | -15.60% |
| Dec 31, 2021 | 5.30B | -22.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lincoln Pharmaceuticals | 12.77B |
| TTK Healthcare | 12.64B |
| Syncom Formulations (India) | 11.55B |
| Fermenta Biotech | 9.39B |
| Wanbury | 9.29B |
| Venus Remedies | 8.70B |
| Bharat Parenterals | 7.87B |
| Fredun Pharmaceuticals | 7.36B |